Study details
Enrolling now
Hyperpolarized 129Xe MR Imaging of Lung Function
Mario Castro, MD, MPH
NCT IDNCT04624490ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
260
Study length
about 6 years
Ages
3+
Locations
1 site in KS
About this study
Researchers are testing a new way to measure lung function using a gas called hyperpolarized xenon. The trial will involve healthy volunteers and people with various lung diseases like asthma, COPD, cystic fibrosis, and interstitial lung disease. It aims to see if this imaging technique can accurately assess how well the lungs are working.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Hyperpolarized Xe129
PhasePhase 1
DrugHyperpolarized Xe129
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Diagnostic Agent (Imaging Contrast Activity)
Body systems
Infectious, Respiratory